Steve Smith

Steve Smith

Company: GemPharmatech

Job title: Director of Business Development


Novel GEM Models For Exploring Neurodegenerative Disease Therapeutics 11:50 am

Challenges with in vivo models for neurodegenerative disease drug development Key attributes of successful CNS disease in vivo models Developing in vivo models for neurodegenerative drug screeningRead more

day: Track B - Day 1 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.